Tech Company Financing Transactions
OncoPep Funding Round
On 4/27/2012, OncoPep raised $2.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
4/27/2012
Transaction Type
Venture Equity
Amount
$2,525,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
520 Boston St. North
Andover, MA 01845
USA
Andover, MA 01845
USA
Phone
Website
Email Address
Overview
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Marc Cohen
Chief Executive Officer
Doris Peterkin
Browse more venture capital transactions:
Prev: 4/27/2012: CloudMine venture capital transaction
Next: 4/27/2012: SendHub venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs